These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23429008)

  • 1. NHE-1: still a viable therapeutic target.
    Karmazyn M
    J Mol Cell Cardiol; 2013 Aug; 61():77-82. PubMed ID: 23429008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach?
    Avkiran M; Cook AR; Cuello F
    Curr Opin Pharmacol; 2008 Apr; 8(2):133-40. PubMed ID: 18222727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NHE-1 in myocardial hypertrophy and remodelling.
    Karmazyn M; Kilić A; Javadov S
    J Mol Cell Cardiol; 2008 Apr; 44(4):647-53. PubMed ID: 18329039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sodium-hydrogen exchange system in the heart: its role in ischemic and reperfusion injury and therapeutic implications.
    Karmazyn M
    Can J Cardiol; 1996 Oct; 12(10):1074-82. PubMed ID: 9191501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.
    Linz WJ; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):239-46. PubMed ID: 14504689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking Na(+)-H+ exchange by cariporide reduces Na(+)-overload in ischemia and is cardioprotective.
    Hartmann M; Decking UK
    J Mol Cell Cardiol; 1999 Nov; 31(11):1985-95. PubMed ID: 10591025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach.
    Kevelaitis E; Qureshi AA; Mouas C; Marotte F; Kevelaitiene S; Avkiran M; Menasché P
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):111-6. PubMed ID: 15621481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.
    Karmazyn M; Sostaric JV; Gan XT
    Drugs; 2001; 61(3):375-89. PubMed ID: 11293648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.
    Kusumoto K; Igata H; Abe A; Ikeda S; Tsuboi A; Imamiya E; Fukumoto S; Shiraishi M; Watanabe T
    Br J Pharmacol; 2002 Apr; 135(8):1995-2003. PubMed ID: 11959803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited effects of post-ischemic NHE blockade on [Na+]i and pHi in rat hearts explain its lack of cardioprotection.
    Ten Hove M; Van Echteld CJ
    Cardiovasc Res; 2004 Feb; 61(3):522-9. PubMed ID: 14962482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitors.
    Lee S; Lee H; Yi KY; Lee BH; Yoo SE; Lee K; Cho NS
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2998-3001. PubMed ID: 15914000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection with cariporide, a sodium-proton exchanger inhibitor, after prolonged ischemia and reperfusion in senescent rats.
    Besse S; Tanguy S; Boucher F; Le Page C; Rozenberg S; Riou B; Leiris Jd; Swynghedauw B
    Exp Gerontol; 2004 Sep; 39(9):1307-14. PubMed ID: 15489053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion.
    Scholz W; Albus U; Counillon L; Gögelein H; Lang HJ; Linz W; Weichert A; Schölkens BA
    Cardiovasc Res; 1995 Feb; 29(2):260-8. PubMed ID: 7736504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
    Kloner RA; Rezkalla SH
    J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury.
    Karmazyn M
    Keio J Med; 1998 Jun; 47(2):65-72. PubMed ID: 9659815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the myocardial sodium-hydrogen exchange for treatment of heart failure.
    Morris K
    Expert Opin Ther Targets; 2002 Jun; 6(3):291-8. PubMed ID: 12223070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Na+/H+ exchange inhibitors: a new class of cardioprotectors].
    Pisarenko OI
    Ross Fiziol Zh Im I M Sechenova; 2004 Sep; 90(9):1103-12. PubMed ID: 15559784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure and physiological role of NHE1 and pharmacological regulation of its activity].
    Spasov AA; Gurova NA; Kharitonova MV
    Eksp Klin Farmakol; 2013; 76(1):43-8. PubMed ID: 23461016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.